Related Experiment Video
Updated: Jun 14, 2025

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Chromatin Regulator SMARCA4 Is Essential for MHV-Induced Inflammatory Cell Death, PANoptosis
R K Subbarao Malireddi1, Thirumala-Devi Kanneganti1
1Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Abstract:
The innate immune system serves as the first line of defense against β-coronaviruses (β-CoVs), a family of viruses that includes SARS-CoV-2. Viral sensing via pattern recognition receptors triggers inflammation and cell death, which are essential components of the innate immune response that facilitate viral clearance. However, excessive activation of the innate immune system and inflammatory cell death can result in uncontrolled release of proinflammatory cytokines, resulting in cytokine storm and pathology. PANoptosis, innate immune, inflammatory cell death initiated by innate immune sensors and driven by caspases and RIPKs through PANoptosome complexes, has been implicated in the pathology of viral infections. Therefore, understanding the molecular mechanisms regulating PANoptosis in response to β-CoV infection is critical for identifying new therapeutic targets that can mitigate disease severity. In the current study, we analyzed findings from a cell death-based CRISPR screen with archetypal β-CoV mouse hepatitis virus (MHV) as the trigger to characterize host molecules required for inflammatory cell death. As a result, we identified SMARCA4, a chromatin regulator, as a putative host factor required for PANoptosis in response to MHV. Furthermore, we observed that gRNA-mediated deletion of Smarca4 inhibited MHV-induced PANoptotic cell death in macrophages. These findings have potential translational and clinical implications for the advancement of treatment strategies for β-CoVs and other infections.
Insights
Researchers identified SMARCA4 as a key factor in PANoptosis, a form of inflammatory cell death, during beta-coronavirus (β-CoV) infection. Inhibiting SMARCA4 may offer new therapeutic strategies for severe viral diseases.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- The innate immune system is crucial for defending against beta-coronaviruses (β-CoVs), including SARS-CoV-2.
- While essential for viral clearance, excessive innate immune activation and inflammatory cell death can lead to severe pathology like cytokine storm.
- PANoptosis, a specific inflammatory cell death pathway, is implicated in viral infection pathology.
Purpose of the Study:
- To identify host factors regulating inflammatory cell death during β-CoV infection.
- To understand the molecular mechanisms underlying PANoptosis triggered by β-CoVs.
- To explore potential therapeutic targets for mitigating β-CoV-induced disease severity.
Main Methods:
- Conducted a cell death-based CRISPR screen using mouse hepatitis virus (MHV), a β-CoV, as a trigger.
- Analyzed host molecules essential for inflammatory cell death.
- Utilized gRNA-mediated deletion of the identified gene in macrophages to assess its role in MHV-induced cell death.
Main Results:
- Identified SMARCA4, a chromatin regulator, as a host factor required for PANoptosis in response to MHV infection.
- Demonstrated that deletion of SMARCA4 significantly inhibited MHV-induced PANoptotic cell death in macrophages.
- Provided evidence for SMARCA4's role in regulating inflammatory cell death pathways during viral infection.
Conclusions:
- SMARCA4 is a critical host regulator of PANoptosis during β-CoV infection.
- Targeting SMARCA4 may represent a novel therapeutic strategy for treating β-CoV infections and associated inflammatory pathologies.
- Findings have potential clinical implications for advancing treatment strategies against β-CoVs and other viral infections.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

